Amerisource Health Services LLC recalls glipiZIDE
- Published
- 22 Jan 2025
- Units affected
- 2,028 units (cartons of 30 individual unit doses)
- Agency
- FDA
- Country
- United States
The hazard
Failed Dissolution Specifications:
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
- Brand / company
- Amerisource Health Services LLC
- Codes / lots
- Lot # 1012910, Exp Date: 04/30/2025
- Distribution
- Nationwide in the USA
- Recall status
- Terminated
Source: U.S. Food and Drug Administration, published 22 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.